The FDA recently approved Eisai's Dayvigo, or lemborexant, as a treatment for adults with insomnia who find it difficult to fall asleep and stay asleep. The drug could also prove beneficial to elderly patients with sleep-related issues caused by mild to moderate Alzheimer's disease.
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.